Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Jacob A. Misenheimer"'
Autor:
Said Hajouli, MD, Jacob A. Misenheimer, MD, Amir Kamran, MD, Kerry Drabish, PhD, APRN, FNP-BC, Frank H. Annie, PhD, MPA, Fahad F. Bafakih, MD, Yodsui F. Hernandez, MD, Ahmad Elashery, MD
Publikováno v:
JACC: Case Reports, Vol 29, Iss 14, Pp 102399- (2024)
Carcinoid syndrome is a constellation of signs and symptoms caused by different hormones produced by carcinoid tumors. Very rarely, those tumors can metastasize to the heart and cause cardiac involvement of the tumor. This study presents a very rare
Externí odkaz:
https://doaj.org/article/0bde51ca4c6248628960f4c9ab10f339
Autor:
Sameer Arora, Paula D. Strassle, Arman Qamar, Evan N. Wheeler, Alexandra L. Levine, Jacob A. Misenheimer, Matthew A. Cavender, George A. Stouffer, Prashant Kaul
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 7 (2018)
BackgroundThe International Classification of Diseases (ICD) coding system does not recognize type 2 myocardial infarction (MI) as a separate entity; therefore, patients with type 2 MI continue to be categorized under the general umbrella of non–ST
Externí odkaz:
https://doaj.org/article/45ec029b80b44b1bbcd2633f8f7891dc
Autor:
Amol A. Bahekar, Sameer Arora, John P. Vavalle, Michael Yeung, Thomas G. Caranasos, Cassandra J. Ramm, Melissa C. Caughey, Jacob A. Misenheimer, Wesley M. Jones
Publikováno v:
Cardiovascular Diagnosis and Therapy. 6:241-249
Background: Transcatheter aortic valve replacement (TAVR) has been approved in patients with high or prohibited surgical risk for surgery for treatment of severe symptomatic aortic stenosis. Prospective studies examining the benefits of TAVR in inter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ef0a17f4f0d9851460e2baf71050dcf
https://doi.org/10.21037/cdt.2016.03.04
https://doi.org/10.21037/cdt.2016.03.04
Publikováno v:
Cardiovascular Diagnosis and Therapy. 7:1-3
Transcatheter aortic valve replacement (TAVR) has become the treatment of choice for patients with severe, symptomatic aortic stenosis with prohibitive risk for valve replacement surgery (SAVR) and is now considered a favourable alternative to surgic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b783dce961481d4a92c53cc5759c6bed
https://doi.org/10.21037/cdt.2016.08.04
https://doi.org/10.21037/cdt.2016.08.04
Autor:
George A. Stouffer, Prashant Kaul, Alexandra L. Levine, Jacob A. Misenheimer, Matthew A. Cavender, Sameer Arora, Arman Qamar, Evan N. Wheeler, Paula D. Strassle
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background The International Classification of Diseases (ICD) coding system does not recognize type 2 myocardial infarction ( MI ) as a separate entity; therefore, patients with type 2 MI continue to be categorized under the general umbrella of non
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1307d5da81e1fed79a1ef2243708ea9
http://europepmc.org/articles/PMC5907605
http://europepmc.org/articles/PMC5907605
Publikováno v:
Catheterization and Cardiovascular Interventions. 87:446-450
Coarctation of the aorta (COA) is one of the more common congenital anomalies, occurring in four in ten thousand live births and accounting for five to eight percent of all congenital heart defects. COA lesions can be challenging to treat percutaneou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2fcdade682134b63fa9329df85f770ac
https://doi.org/10.1002/ccd.26165
https://doi.org/10.1002/ccd.26165
Autor:
Sameer Arora, Paula D. Strassle, Matthew A. Cavender, Thomas G. Caranasos, John P. Vavalle, Satyanarayana R. Vaidya, Jacob A. Misenheimer, Evan N. Wheeler, Cassandra J. Ramm, Jeremy A. Rhodes
Publikováno v:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventions. 91(4)
Background In the recently concluded PARTNER 2 trial, TF-TAVR cohort was shown to have lower risks of death or disabling strokes as compared to SAVR, whereas the outcomes with transthoracic TAVR were comparable with SAVR. Methods We searched PubMed,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba3d966eca7a707687ba1e7cbef8a5f7
https://pubmed.ncbi.nlm.nih.gov/29068166
https://pubmed.ncbi.nlm.nih.gov/29068166
Publikováno v:
The Journal of heart valve disease. 25(6)
Following publication of the results of the PARTNER trial, the American College of Cardiology/American Heart Association recognized the success of transcatheter aortic valve replacement (TAVR) by incorporating it as a feasible option in high-surgical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::23440ae75372fd44f6a1786c3a101952
https://pubmed.ncbi.nlm.nih.gov/28290162
https://pubmed.ncbi.nlm.nih.gov/28290162
Aortic stenosis is the most common valvular heart disease in the developed world. About 7% of the population over age 65 years suffers from degenerative aortic stenosis. The prognosis of patients with symptomatic severe aortic stenosis is dismal with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa306f271a98358f32a0fce98ff4ec1a
Publikováno v:
JACC. Cardiovascular interventions. 9(16)
A 44-year-old man with prior Nissen fundoplication presented with chest pain, hypotension, tachycardia, and inferior ST-segment elevation on electrocardiography. Coronary angiography demonstrated normal coronaries, and left ventriculography revealed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a4d4d6d11cbee791d71be97015bd990
https://pubmed.ncbi.nlm.nih.gov/27539697
https://pubmed.ncbi.nlm.nih.gov/27539697